Orgad Laub
Director Ejecutivo en Sealantium Medical Ltd. .
Perfil
Orgad Laub is the founder and Chief Executive Officer of Sealantium Medical Ltd.
which is founded in 2011.
He is currently a Director at Rimonyx Pharmaceuticals Ltd.
Dr. Laub has also worked as a Director at Serono Corp.
and as a Professor at Weizmann Institute of Science.
Cargos activos de Orgad Laub
| Empresas | Cargo | Inicio |
|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Director/Miembro de la Junta | - |
Sealantium Medical Ltd.
 Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Director Ejecutivo | 01/01/2011 |
Antiguos cargos conocidos de Orgad Laub.
| Empresas | Cargo | Fin |
|---|---|---|
| Serono Corp. | Director/Miembro de la Junta | - |
| Weizmann Institute of Science | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| Serono Corp. | |
Sealantium Medical Ltd.
Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Orgad Laub
